At a glance
We’re excited to see you in Indianapolis!
Our mission is to help you personalize diagnosis and treatment for your patients with thyroid nodules. Stop by booth #909 to learn how Veracyte is using whole-transcriptome-derived analysis on every sample to provide an actionable Afirma GSC report and create the potential for novel research.
Featured Presentations & Posters
| Title | Session | Date | Time | Presenter | Location |
|---|
Development of Novel mRNA Classifiers to Stratify Preoperative Thyroid Tumor Risk | “Best of Scientific Orals” | Oral Presentation | Sunday, October 12 | 1:42 – 1:48 PM ET | Thomas F. Barrett, M.D., Jr., Washington University – St Louis | Location:120 |
Development of Novel mRNA Classifiers to Stratify Preoperative Thyroid Tumor Risk | Oral Presentation | Sunday, October 12 | 1:42 – 1:48 PM ET | Thomas F. Barrett, M.D., Jr., Washington University – St Louis | Location: 128 |
The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules | Oral Presentation | Sunday, October 12 | 2:36 – 2:42 PM ET | Emma R. De Ravin, MD, Thomas Jefferson University | Location: 128 |
Tags
North America
Afirma Thyroid
Afirma GRID